These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3551060

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus].
    Perusicová J, Bárová H, Hill M, Masek Z.
    Vnitr Lek; 2002 Jun; 48(6):490-9. PubMed ID: 12132349
    [Abstract] [Full Text] [Related]

  • 4. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N.
    Eur J Med Res; 2003 Jul 31; 8(7):295-303. PubMed ID: 12911866
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasma glucose response after intravenous injection of tolbutamide in insulin-treated type I and type II diabetic patients.
    Mokuda O, Murakami I, Ikeda T, Tominaga M, Mashiba H.
    Exp Clin Endocrinol; 1988 Aug 31; 91(3):265-70. PubMed ID: 3075183
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL, Wolf SL, Kabadi UM.
    Arch Intern Med; 1996 Feb 12; 156(3):259-64. PubMed ID: 8572835
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [C-peptide measurement in the classification of diabetes mellitus and in the assessment of requirements for insulin treatment].
    Gjessing HJ.
    Ugeskr Laeger; 1990 Feb 26; 152(9):588-93. PubMed ID: 2408222
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum adiponectin is associated with fasting serum C-peptide in non-obese diabetic patients.
    Furuta M, Tamai M, Hanabusa T, Yamamoto Y, Nanjo K, Sanke T.
    Diabetes Res Clin Pract; 2006 Jun 26; 72(3):302-7. PubMed ID: 16442181
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Classification of diabetes in patients with end-stage renal disease. Validation of clinical criteria according to fasting plasma C-peptide.
    Benhamou PY, Marwah T, Balducci F, Zmirou D, Borgel F, Cordonnier D, Halimi S, Papoz L.
    Clin Nephrol; 1992 Nov 26; 38(5):239-44. PubMed ID: 1451336
    [Abstract] [Full Text] [Related]

  • 18. [Clinical significance of measuring serum c-peptide before and after glucagon injection].
    Kan Y, Chi Z.
    Zhonghua Yi Xue Za Zhi; 1991 Jan 26; 71(1):16-7, 4. PubMed ID: 1850647
    [Abstract] [Full Text] [Related]

  • 19. [C-peptide measurement in patients with type II diabetes mellitus: its possible use in the insulin therapy decision].
    Tamez-Pérez HE, García-Vallejo C, Santos-Flores R, González-Martínez PM, Lojero-Wheatley L, Valdovinos-Chávez S.
    Arch Invest Med (Mex); 1990 Jan 26; 21(2):123-6. PubMed ID: 2103699
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.